1.57 USD
-0.1 (-5.99%)
We assign a fundamental rating of 1 out of 10 to BNBX. BNBX was compared to 57 industry peers in the Life Sciences Tools & Services industry. BNBX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BNBX has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- BNBX had negative earnings in the past year.
- In the past year BNBX has reported a negative cash flow from operations.
- In the past 5 years BNBX always reported negative net income.
- In the past 5 years BNBX always reported negative operating cash flow.
1.2 Ratios
- BNBX has a worse Return On Assets (-1565.95%) than 96.49% of its industry peers.
- BNBX's Return On Equity of -3014.91% is on the low side compared to the rest of the industry. BNBX is outperformed by 92.98% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1565.95% | ||
| ROE | -3014.91% | ||
| ROIC | N/A |
ROA(3y)-565.1%
ROA(5y)-366.41%
ROE(3y)-1098.28%
ROE(5y)-697.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- BNBX's Gross Margin of 33.24% is on the low side compared to the rest of the industry. BNBX is outperformed by 64.91% of its industry peers.
- BNBX's Gross Margin has declined in the last couple of years.
- BNBX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 33.24% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.17%
GM growth 5Y-8.93%
2. Health
2.1 Basic Checks
- BNBX does not have a ROIC to compare to the WACC, probably because it is not profitable.
- BNBX has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, BNBX has more shares outstanding
- There is no outstanding debt for BNBX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- Based on the Altman-Z score of -129.02, we must say that BNBX is in the distress zone and has some risk of bankruptcy.
- BNBX's Altman-Z score of -129.02 is on the low side compared to the rest of the industry. BNBX is outperformed by 94.74% of its industry peers.
- There is no outstanding debt for BNBX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -129.02 |
ROIC/WACCN/A
WACC11.06%
2.3 Liquidity
- A Current Ratio of 0.91 indicates that BNBX may have some problems paying its short term obligations.
- With a Current ratio value of 0.91, BNBX is not doing good in the industry: 89.47% of the companies in the same industry are doing better.
- A Quick Ratio of 0.87 indicates that BNBX may have some problems paying its short term obligations.
- BNBX has a worse Quick ratio (0.87) than 87.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.91 | ||
| Quick Ratio | 0.87 |
3. Growth
3.1 Past
- BNBX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.27%, which is quite impressive.
- BNBX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -21.79%.
- Measured over the past years, BNBX shows a small growth in Revenue. The Revenue has been growing by 2.04% on average per year.
EPS 1Y (TTM)84.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.32%
Revenue 1Y (TTM)-21.79%
Revenue growth 3Y-51.01%
Revenue growth 5Y2.04%
Sales Q2Q%-75.48%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y77.08%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year40%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for BNBX. In the last year negative earnings were reported.
- Also next year BNBX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- BNBX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:BNBX (1/20/2026, 8:00:02 PM)
1.57
-0.1 (-5.99%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)12-15 2025-12-15/amc
Earnings (Next)02-11 2026-02-11
Inst Owners0.99%
Inst Owner ChangeN/A
Ins Owners4.64%
Ins Owner Change65.99%
Market Cap6.83M
Revenue(TTM)2.68M
Net Income(TTM)-69.49M
Analysts43.33
Price TargetN/A
Short Float %4.73%
Short Ratio1.47
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-82.3%
Min Revenue beat(2)-87.98%
Max Revenue beat(2)-76.62%
Revenue beat(4)1
Avg Revenue beat(4)-42.54%
Min Revenue beat(4)-87.98%
Max Revenue beat(4)13.1%
Revenue beat(8)2
Avg Revenue beat(8)-25.08%
Revenue beat(12)5
Avg Revenue beat(12)-17.71%
Revenue beat(16)8
Avg Revenue beat(16)-10.94%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2.54 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.96 | ||
| P/tB | 2.96 | ||
| EV/EBITDA | N/A |
EPS(TTM)-685.76
EYN/A
EPS(NY)-84.15
Fwd EYN/A
FCF(TTM)-2.95
FCFYN/A
OCF(TTM)-2.88
OCFYN/A
SpS0.62
BVpS0.53
TBVpS0.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1565.95% | ||
| ROE | -3014.91% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 33.24% | ||
| FCFM | N/A |
ROA(3y)-565.1%
ROA(5y)-366.41%
ROE(3y)-1098.28%
ROE(5y)-697.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.17%
GM growth 5Y-8.93%
F-Score4
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 81.49% | ||
| Cap/Sales | 11.67% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.91 | ||
| Quick Ratio | 0.87 | ||
| Altman-Z | -129.02 |
F-Score4
WACC11.06%
ROIC/WACCN/A
Cap/Depr(3y)74.6%
Cap/Depr(5y)112.72%
Cap/Sales(3y)14.16%
Cap/Sales(5y)14.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.32%
EPS Next Y77.08%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-21.79%
Revenue growth 3Y-51.01%
Revenue growth 5Y2.04%
Sales Q2Q%-75.48%
Revenue Next Year40%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-14.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y9.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.7%
OCF growth 3YN/A
OCF growth 5YN/A
BNB PLUS CORP / BNBX FAQ
Can you provide the ChartMill fundamental rating for BNB PLUS CORP?
ChartMill assigns a fundamental rating of 1 / 10 to BNBX.
What is the valuation status for BNBX stock?
ChartMill assigns a valuation rating of 0 / 10 to BNB PLUS CORP (BNBX). This can be considered as Overvalued.
What is the profitability of BNBX stock?
BNB PLUS CORP (BNBX) has a profitability rating of 0 / 10.
Can you provide the expected EPS growth for BNBX stock?
The Earnings per Share (EPS) of BNB PLUS CORP (BNBX) is expected to grow by 77.08% in the next year.